| Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey JM Darves‐Bornoz, J Alonso, G de Girolamo, R Graaf, JM Haro, ... Journal of traumatic stress 21 (5), 455-462, 2008 | 434 | 2008 |
| Chronic pain in Parkinson's disease: the cross‐sectional French DoPaMiP survey L Nègre‐Pagès, W Regragui, D Bouhassira, H Grandjean, O Rascol Movement disorders: official journal of the Movement Disorder Society 23 (10 …, 2008 | 384 | 2008 |
| Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease S Perez-Lloret, L Negre-Pages, P Damier, A Delval, P Derkinderen, ... JAMA neurology 71 (7), 884-890, 2014 | 337 | 2014 |
| Adherence to antiparkinson medication in a multicenter European study D Grosset, A Antonini, M Canesi, G Pezzoli, A Lees, K Shaw, E Cubo, ... Movement disorders: official journal of the Movement Disorder Society 24 (6 …, 2009 | 227 | 2009 |
| Anxious and depressive symptoms in Parkinson's disease: the French cross‐sectionnal DoPaMiP study L Nègre‐Pagès, H Grandjean, M Lapeyre‐Mestre, JL Montastruc, ... Movement Disorders 25 (2), 157-166, 2010 | 221 | 2010 |
| Prévalence et comorbidité des troubles psychiatriques dans la population générale française: résultats de l’étude épidémiologique ESEMeD/MHEDEA 2000/(ESEMeD) JP Lépine, I Gasquet, V Kovess, S Arbabzadeh-Bouchez, L Nègre-Pagès, ... L'encéphale 31 (2), 182-194, 2005 | 196 | 2005 |
| Factors associated with overweight in preschool-age children in southwestern France B Jouret, N Ahluwalia, C Cristini, M Dupuy, L Nègre-Pages, H Grandjean, ... The American journal of clinical nutrition 85 (6), 1643-1649, 2007 | 162 | 2007 |
| Prevalence and comorbidity of psychiatric disorders in the French general population JP Lépine, I Gasquet, V Kovess, S Arbabzadeh-Bouchez, L Negre-Pages, ... L'encephale 31 (2), 182-194, 2005 | 160 | 2005 |
| Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function … O Hanon, JP Berrou, L Negre-Pages, JH Goch, Z Nádházi, R Petrella, ... Journal of hypertension 26 (8), 1642-1650, 2008 | 111 | 2008 |
| Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort S Perez‐Lloret, L Nègre‐Pagès, A Ojero‐Senard, P Damier, A Destée, ... European journal of neurology 19 (1), 28-37, 2012 | 109 | 2012 |
| Prevention of overweight in preschool children: results of kindergarten-based interventions B Jouret, N Ahluwalia, M Dupuy, C Cristini, L Negre-Pages, H Grandjean, ... International journal of obesity 33 (10), 1075-1083, 2009 | 91 | 2009 |
| Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study I Gasquet, L Nègre-Pagès, A Fourrier, G Nachbaur, A El-Hasnaoui, ... L'encephale 31 (2), 195-206, 2005 | 84 | 2005 |
| Falls in ambulatory non-demented patients with Parkinson’s disease O Rascol, S Perez-Lloret, P Damier, A Delval, P Derkinderen, A Destée, ... Journal of Neural Transmission 122, 1447-1455, 2015 | 74 | 2015 |
| Usage des psychotropes et troubles psychiatriques en France: résultats de l’étude épidémiologique ESEMeD/MHEDEA 2000/(ESEMeD) en population générale I Gasquet, L Nègre-Pagès, A Fourrier, G Nachbaur, A El-Hasnaoui, ... L'encéphale 31 (2), 195-206, 2005 | 66 | 2005 |
| Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort PL Ratti, L Nègre-Pagès, S Pérez-Lloret, R Manni, P Damier, F Tison, ... Parkinsonism & related disorders 21 (11), 1323-1329, 2015 | 58 | 2015 |
| L‐DOPA‐induced dyskinesias, motor fluctuations and health‐related quality of life: the COPARK survey S Perez‐Lloret, L Negre‐Pages, P Damier, A Delval, P Derkinderen, ... European Journal of Neurology 24 (12), 1532-1538, 2017 | 56 | 2017 |
| Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (“n-of-1”) exploratory trial of simvastatin … F Tison, L Nègre-Pagès, WG Meissner, S Dupouy, Q Li, ML Thiolat, ... Parkinsonism & Related Disorders 19 (4), 416-421, 2013 | 37 | 2013 |
| The interest of gait markers in the identification of subgroups among fibromyalgia patients B Auvinet, D Chaleil, J Cabane, A Dumolard, P Hatron, R Juvin, ... BMC musculoskeletal disorders 12, 1-9, 2011 | 36 | 2011 |
| A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease O Rascol, J Ferreira, L Nègre‐Pages, S Perez‐Lloret, L Lacomblez, ... Fundamental & clinical pharmacology 26 (4), 557-564, 2012 | 35 | 2012 |
| Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients A Pathak, O Hanon, L Negre‐Pages, F Sevenier, Oscar Investigators Fundamental & clinical pharmacology 21 (2), 199-205, 2007 | 24 | 2007 |
